Companies / Kymera Therapeutics, Inc. / Activity
Activity — Kymera Therapeutics, Inc.
109 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $96.1K | -1K -1.92% | 61,202 0.07% of shares | low |
| Mar 20, 2026 | Esposito Pamela Director | Sell | Common Stock | $95.9K | -1K -100.00% | 0 0.00% of shares | low |
| Apr 1, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $94.7K | -1K -1.77% | 61,202 0.07% of shares | low |
| Jan 20, 2026 | Esposito Pamela Director | Exercise | Common Stock | $93.6K | +3K | 3,000 <0.01% of shares | low |
| Mar 2, 2026 | Gollob Jared Executive | Sell | Common Stock | $93.4K | -1K -0.84% | 125,077 0.15% of shares | low |
| Feb 25, 2026 | Mainolfi Nello CEO | Exercise | Common Stock | $62.4K | +30K +4.50% | 696,195 0.84% of shares | low |
| Apr 15, 2026 | Chadwick Jeremy G Executive | Exercise | Common Stock | $56.5K | +1K +2.12% | 62,502 0.08% of shares | low |
| Mar 20, 2026 | Esposito Pamela Director | Sell | Common Stock | $54.4K | -700 -28.00% | 1,800 <0.01% of shares | low |
| Feb 20, 2026 | Esposito Pamela Director | Sell | Common Stock | $52.9K | -600 -100.00% | 0 0.00% of shares | low |
| May 27, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $49.2K | -600 -1.34% | 44,018 0.05% of shares | low |
| Mar 2, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $48.2K | -549 -0.69% | 79,219 0.10% of shares | low |
| Mar 20, 2026 | Esposito Pamela Director | Sell | Common Stock | $47.5K | -600 -33.33% | 1,200 <0.01% of shares | low |
| May 26, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $44.5K | -551 -1.13% | 48,297 0.06% of shares | low |
| Mar 4, 2026 | Gollob Jared Executive | Sell | Common Stock | $41.3K | -492 -0.40% | 121,537 0.15% of shares | low |
| Mar 4, 2026 | Jacobs Bruce N. Executive | Sell | Common Stock | $41.3K | -492 -0.21% | 236,991 0.29% of shares | low |
| Mar 4, 2026 | Gollob Jared Executive | Sell | Common Stock | $38.7K | -447 -0.38% | 117,134 0.14% of shares | low |
| Mar 4, 2026 | Jacobs Bruce N. Executive | Sell | Common Stock | $38.7K | -447 -0.19% | 232,588 0.28% of shares | low |
| Apr 14, 2026 | Chadwick Jeremy G Executive | Exercise | Common Stock | $34.1K | +785 +1.20% | 66,453 0.08% of shares | low |
| Mar 2, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $33.9K | -383 -0.48% | 78,836 0.09% of shares | low |
| Mar 4, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $33.1K | -394 -0.51% | 77,335 0.09% of shares | low |
| Mar 4, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $31.0K | -358 -0.48% | 73,810 0.09% of shares | low |
| Apr 22, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $27.0K | -300 -0.49% | 61,202 0.07% of shares | low |
| Jan 20, 2026 | Esposito Pamela Director | Sell | Common Stock | $26.7K | -400 -7.27% | 5,100 <0.01% of shares | low |
| May 26, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $25.7K | -324 -0.56% | 57,148 0.07% of shares | low |
| Jan 20, 2026 | Esposito Pamela Director | Sell | Common Stock | $13.7K | -200 -100.00% | 0 0.00% of shares | low |
| Apr 22, 2026 | Chadwick Jeremy G Executive | Exercise | Common Stock | $8.7K | +200 +0.33% | 61,502 0.07% of shares | low |
| Apr 22, 2026 | Chadwick Jeremy G Executive | Exercise | Common Stock | $3.0K | +100 +0.16% | 61,302 0.07% of shares | low |
| Feb 25, 2026 | Mainolfi Nello CEO | Sell | Common Stock | $748 | -8 -0.00% | 666,195 0.80% of shares | low |
| Mar 2, 2026 | Gollob Jared Executive | Grant | Common Stock | $0 | +18K +16.05% | 127,642 0.15% of shares | low |
| Mar 2, 2026 | Jacobs Bruce N. Executive | Grant | Common Stock | $0 | +18K +7.76% | 245,059 0.29% of shares | low |
| Mar 2, 2026 | Adams Brian Executive | Grant | Common Stock | $0 | +4K +7.86% | 56,625 0.07% of shares | low |
| Mar 2, 2026 | Chadwick Jeremy G Executive | Grant | Common Stock | $0 | +13K +18.71% | 79,768 0.10% of shares | low |
| Mar 2, 2026 | Goodman Noah Executive | Grant | Common Stock | $0 | +9K +18.42% | 59,306 0.07% of shares | low |
| Apr 22, 2026 | Chadwick Jeremy G Executive | Exercise | Stock Option (Right to Buy) | — | -200 -0.34% | 58,263 0.07% of shares | low |
| Apr 22, 2026 | Chadwick Jeremy G Executive | Exercise | Stock Option (Right to Buy) | — | -100 -0.22% | 45,434 0.05% of shares | low |
| Apr 15, 2026 | Chadwick Jeremy G Executive | Exercise | Stock Option (Right to Buy) | — | -1K -2.18% | 58,463 0.07% of shares | low |
| Apr 14, 2026 | Chadwick Jeremy G Executive | Exercise | Stock Option (Right to Buy) | — | -785 -1.30% | 59,763 0.07% of shares | low |
| Apr 14, 2026 | Chadwick Jeremy G Executive | Exercise | Stock Option (Right to Buy) | — | -4K -8.93% | 45,534 0.05% of shares | low |
| Apr 1, 2026 | Chadwick Jeremy G Executive | Exercise | Stock Option (Right to Buy) | — | -15K -17.58% | 68,633 0.08% of shares | low |
| Mar 31, 2026 | Chadwick Jeremy G Executive | Exercise | Stock Option (Right to Buy) | — | -8K -8.36% | 83,273 0.10% of shares | low |
| Jun 24, 2026 | Maraganore John Director | Grant | Stock Option (Right to Buy) | — | +6K | 6,068 <0.01% of shares | low |
| Jun 24, 2026 | Baker Bros. Advisors LP Director | Grant | Non-Qualified Stock Option (right to buy) | — | +6K | 6,068 <0.01% of shares | low |
| Jun 24, 2026 | Baker Bros. Advisors LP Director | Grant | Non-Qualified Stock Option (right to buy) | — | +6K | 6,068 <0.01% of shares | low |
| Jun 24, 2026 | Bvf Partners L P/IL Director | Grant | Stock Option (Right to Buy) | — | +6K | 6,068 <0.01% of shares | low |
| Mar 2, 2026 | Gollob Jared Executive | Grant | Stock Option (Right to Buy) | — | +35K | 35,300 0.04% of shares | low |
| Mar 2, 2026 | Mainolfi Nello CEO | Grant | Stock Option (Right to Buy) | — | +215K | 215,000 0.26% of shares | low |
| Feb 25, 2026 | Mainolfi Nello CEO | Exercise | Stock Option (Right to Buy) | — | -30K -10.89% | 245,559 0.30% of shares | low |
| Jan 5, 2026 | Mainolfi Nello CEO | Exercise | Stock Option (Right to Buy) | — | -3K -0.69% | 446,882 0.54% of shares | low |
| Mar 2, 2026 | Jacobs Bruce N. Executive | Grant | Stock Option (Right to Buy) | — | +35K | 35,300 0.04% of shares | low |
| Mar 25, 2026 | Chadwick Jeremy G Executive | Exercise | Stock Option (Right to Buy) | — | -25K -21.39% | 90,873 0.11% of shares | low |